We are live on ! Find out more
FC

Finepoint Capital Portfolio holdings

AUM $1.95B
1-Year Est. Return 45.61%
This Fund
S&P 500
This Quarter Est. Return
+55.33%
1 Year Est. Return
+45.61%
3 Year Est. Return
+24.83%
5 Year Est. Return
+26.66%
10 Year Est. Return
–
AUM
$1.36B
AUM Growth
+$44.3M
Cap. Flow
-$217M
Cap. Flow %
-15.99%
Top 10 Hldgs %
100%
Holding
25
New
–
Increased
2
Reduced
2
Closed
15

Top Buys

Rank Stock Value
1
LLYVK icon
Liberty Live Group Series C
LLYVK
+$7.68M

Top Sells

Rank Stock Value
1
QXO
QXO Inc
QXO
+$54.4M
2
LBRDK icon
Liberty Broadband Class C
LBRDK
+$45M
3
SWTX
SpringWorks Therapeutics
SWTX
+$32.2M
4
ASND icon
Ascendis Pharma A/S
ASND
+$28M
5
RVMD icon
Revolution Medicines
RVMD
+$24.4M

Sector Composition

Rank Sector Weight
1 Industrials 33.61%
2 Communication Services 3.22%
3 Healthcare 0.35%
4 Energy 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$725M 53.49%
1,173,500
+418,500
+55% +$239M
QXO
2
QXO Inc
QXO
$14.9B
$456M 33.61%
21,152,868
-3,315,292
-14% -$54.4M
IWM icon
3
PUT
iShares Russell 2000 ETF
IWM
$82.2B
$126M 9.31%
585,000
-900,000
-61% -$181M
LLYVK icon
4
Liberty Live Group Series C
LLYVK
$9.45B
$43.6M 3.22%
537,051
+104,156
+24% +$7.68M
SLDB icon
5
Solid Biosciences
SLDB
$858M
$4.68M 0.35%
961,251
– –
ANNA
6
AleAnna Inc
ANNA
$141M
$200K 0.01%
27,717
– –
ANNAW
7
AleAnna Inc Warrant
ANNAW
$12.5M
$115K 0.01%
490,000
– –
MNYWW
8
MoneyHero Ltd Warrants
MNYWW
$41.9K ﹤0.01%
895,000
– –
LSBPW
9
DELISTED
LakeShore Biopharma Warrants
LSBPW
$19.6K ﹤0.01%
489,999
– –
CLDI icon
10
Calidi Biotherapeutics
CLDI
$2.3M
$2.88K ﹤0.01%
1,042
– –
ARVN icon
11
Arvinas
ARVN
$517M
– –
-694,028
Closed -$4.87M
ASND icon
12
Ascendis Pharma A/S
ASND
$17.1B
– –
-179,872
Closed -$28M
CYTK icon
13
Cytokinetics
CYTK
$10.9B
– –
-309,948
Closed -$12.5M
EYPT icon
14
EyePoint Inc
EYPT
$1.12B
– –
-1,081,954
Closed -$5.86M
LKFT
15
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.97B
– –
-656,587
Closed -$16.5M
LBRDK icon
16
Liberty Broadband Class C
LBRDK
$4.43B
– –
-529,240
Closed -$45M
MLTX icon
17
MoonLake Immunotherapeutics
MLTX
$1.64B
– –
-435,785
Closed -$17M
PRTA icon
18
Prothena Corp
PRTA
$453M
– –
-640,071
Closed -$7.92M
RLAY icon
19
Relay Therapeutics
RLAY
$4.34B
– –
-2,117,646
Closed -$5.55M
RNAM
20
DELISTED
Avidity Biosciences
RNAM
– –
-380,700
Closed -$11.2M
RVMD icon
21
Revolution Medicines
RVMD
$39.6B
– –
-691,260
Closed -$24.4M
SRPT icon
22
Sarepta Therapeutics
SRPT
$1.82B
– –
-157,555
Closed -$10.1M
SWTX
23
DELISTED
SpringWorks Therapeutics
SWTX
– –
-728,602
Closed -$32.2M
XNCR icon
24
Xencor
XNCR
$1.3B
– –
-642,200
Closed -$6.83M
GATEW
25
DELISTED
Marblegate Acquisition Corp. Warrant
GATEW
– –
-735,000
Closed -$118K

Similar funds

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $1.95B AUM 15.9% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return
FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return
NFG
Nations Financial Group Cedar Rapids, Iowa $1.94B AUM 25.76% 1-Year Est. Return
MWA
Midland Wealth Advisors Effingham, Illinois $1.94B AUM 14.31% 1-Year Est. Return

Finepoint Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Finepoint Capital held 25 positions worth $1.36B, up 3.4% from $1.31B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Finepoint Capital withdrew a net $217M in Q2 2025, closing 15 positions and reducing 2 holdings. Its most notable exit was Liberty Broadband Class C, an estimated $45M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 34% of assets, up from 25% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Finepoint Capital added an estimated $7.68M to Liberty Live Group Series C.

  • Finepoint Capital added most to Liberty Live Group Series C in Q2 2025, an estimated $7.68M increase.
  • Finepoint Capital's biggest Q2 2025 reduction was QXO Inc, cutting an estimated $54.4M.
  • Finepoint Capital fully exited Liberty Broadband Class C in Q2 2025, selling an estimated $45M.
  • Finepoint Capital's ten largest holdings make up 100% of its $1.36B portfolio in Q2 2025.
  • Finepoint Capital opened 0 new positions and closed 15 in Q2 2025.
  • Finepoint Capital's portfolio value rose 3.4% quarter-over-quarter to $1.36B.

Based on Finepoint Capital's 13F filing for Q2 2025, filed 13 Aug 2025.